Multivariate analyses of mometosome furoate versus fixed dose combination of salmeterol and fluticasone propionate in mild persistent asthma using an administrative claims database

被引：0
|
作者：
McLaughlin, J.
Navaratnam, P. [1 ]
Urdaneta, E. [2 ]
Friedman, H. S.
机构：
[1] Informagenics, Worthington, OH USA
[2] Analytic Solutions, New York, NY USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2009年 / 123卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
157
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 38 条
  • [31] The assessment of effectiveness, tolerance, and patient satisfaction with the use of a new fixed-dose combination product, containing salmeterol and fluticasone propionate, Salflumix Easyhaler® in the treatment of asthma in the daily clinical practice
    Doniec, Zbigniew
    Olszanecka-Glinianowicz, Magdalena
    Hantulik, Piotr
    Almgren-Rachtan, Agnieszka
    Chudek, Jerzy
    JOURNAL OF ASTHMA, 2023, 60 (04) : 754 - 760
  • [32] Comparison of Patient-Reported Outcomes During Treatment With Adjustable- and Fixed-Dose Budesonide/Formoterol Pressurized Metered-Dose Inhaler Versus Fixed-Dose Fluticasone Propionate/Salmeterol Dry Powder Inhaler in Patients With Asthma
    O'Connor, Richard D.
    Patrick, Donald L.
    Parasuraman, Bhash
    Martin, Paula
    Goldman, Mitchell
    JOURNAL OF ASTHMA, 2010, 47 (02) : 217 - 223
  • [33] Long-term use of fluticasone propionate/salmeterol fixed-dose combination and incidence of cataracts and glaucoma among chronic obstructive pulmonary disease patients in the UK General Practice Research Database
    Miller, David P.
    Watkins, Stephanie E.
    Sampson, Tim
    Davis, Kourtney J.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2011, 6 : 467 - 476
  • [34] A Post-Hoc Analysis Of Asthma Control And Lung Function Following Treatment With Ciclesonide 80 μg HFA-MDI Twice Daily In Subjects With Mild-to-Moderate Persistent Asthma Previously Receiving Low Dose Fluticasone Propionate/Salmeterol
    Prenner, B.
    Meltzer, E. O.
    Desai, S. Y.
    Karafilidis, J.
    Walsh, J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB85 - AB85
  • [35] Fixed-dose combination of indacaterol/glycopyrronium/mometasone furoate once-daily versus salmeterol/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: A randomised, Phase IIIb, non-inferiority study (ARGON)
    Gessner, Christian
    Kornmann, Oliver
    Maspero, Jorge
    van Zyl-Smit, Richard
    Kruell, Matthias
    Salina, Anna
    Gupta, Pritam
    Bostel, Sebastien
    Fucile, Sebastian
    Conde, Lorena Garcia
    Pfister, Pascal
    RESPIRATORY MEDICINE, 2020, 170
  • [36] Clinical equivalence of salmeterol/fluticasone propionate in combination (50/100 μg twice daily) when administered via a chlorofluorocarbon-free metered dose inhaler or dry powder inhaler to patients with mild-to-moderate asthma
    Bateman, ED
    Silins, V
    Bogolubov, M
    RESPIRATORY MEDICINE, 2001, 95 (02) : 136 - 146
  • [37] One time a day mometasone/indacaterol fixed-dose combination versus two times a day fluticasone/salmeterol in patients with inadequately controlled asthma: pooled analysis from PALLADIUM and IRIDIUM studies
    Chapman, Kenneth
    van Zyl-Smit, Richard
    Maspero, Jorge
    Kerstjens, Huib A. M.
    Gon, Yasuhiro
    Hosoe, Motoi
    Tanase, Ana-Maria
    Pethe, Abhijit
    Shu, Xu
    D'Andrea, Peter
    BMJ OPEN RESPIRATORY RESEARCH, 2021, 8 (01)
  • [38] Fixed-dose combination of indacaterol/glycopyrronium/ mometasone furoate once-daily versus salmeterol/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: A randomised, Phase IIIb, non-inferiority study (ARGON) (vol 170, 106021, 2020)
    Gessner, Christian
    Kornmann, Oliver
    Maspero, Jorge
    van Zyl-Smit, Richard
    Kruell, Matthias
    Salina, Anna
    Gupta, Pritam
    Bostel, Sebastien
    Fucile, Sebastian
    Conde, Lorena Garcia
    Pfister, Pascal
    RESPIRATORY MEDICINE, 2020, 175
1234